Rat Anti-EFNA4 Monoclonal Antibody (8K23) (CBMAB-1181-YC)

Zhao, X., Chen, Y., Sun, X., He, Z., Wu, T., Wu, C., ... & Liu, X. S. (2022). Oncogenic EFNA4 amplification promotes lung adenocarcinoma lymph node metastasis. Cancers, 14(17), 4226.

Rowe, D. W., Hong, S. H., Zhang, C., Shin, D. G., Adams, D. J., Youngstrom, D. W., ... & Maye, P. (2021). Skeletal screening IMPC/KOMP using μCT and computer automated cryohistology: application to the Efna4 KO mouse line. Bone, 144, 115688.

Lin, J., Zeng, C., Zhang, J., Song, Z., Qi, N., Liu, X., ... & Chen, F. (2021). EFNA4 promotes cell proliferation and tumor metastasis in hepatocellular carcinoma through a PIK3R2/GSK3β/β-catenin positive feedback loop. Molecular Therapy-Nucleic Acids, 25, 328-341.

Garrido‐Laguna, I., Krop, I., Burris III, H. A., Hamilton, E., Braiteh, F., Weise, A. M., ... & Hong, D. S. (2019). First‐in‐human, phase I study of PF‐06647263, an anti‐EFNA4 calicheamicin antibody–drug conjugate, in patients with advanced solid tumors. International journal of cancer, 145(7), 1798-1808.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols